Alvion is a science-oriented pharmaceutical company that specializes in the development and manufacturing of non-infringing generic medicines in Europe. With a focus on research and development, intellectual property, quality, regulatory affairs, and manufacturing, Alvion has established itself as a private and independent company with a track record of excellence.

Driven by a best-in-class approach, Alvion is launching a wide portfolio of products and services across multiple regions including EU, MENA, Canada, Australia, South Africa, and Latin America. Through partnerships with renowned multinational pharmaceutical companies, Alvion aims to deliver affordable medicines with an efficient supply chain, ensuring that their products are among the first to market prior to patent expiry.

As an extroverted pharmaceutical company, Alvion also develops medicines for licensing partners, establishing a dynamic business model that supports multinational and local partners across a wide territory.

With a vision to set a new standard in generics and an understanding of global healthcare needs, Alvion strives to offer difficult-to-develop non-infringing products to thirty markets, enriching the quality of life and delivering outstanding value to all stakeholders. Their goal is to become a leading and vertically integrated pharmaceutical company with a global presence, serving healthcare communities and fostering high-performance employees.

© 2023 Alvion. All rights reserved. Privacy Preference Center. Privacy Preferences.